ATP5IF1 and carcinoma: Previously, proteomic analysis revealed downregulation of IF1 in NALM-6 and SUM 159 cells treated with ONC201 [10,24], which is the opposite of an increased expression of IF1 observed in various types of carcinomas and its role in the metabolic shift from oxidative phosphorylation toward glycolysis has been discussed [38].